Expression of tumour necrosis factor-related apoptosis-inducing ligand and caspase-3 in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C

Histopathology

Volumn 51, Issue 5, 2007, Pages 597-604

  Piekarska, A ^a   Kubiak, R ^a   Omulecka, A ^a   Szymczak, W ^b   Piekarski, J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Caspase 3; Chronic hepatitis C; Tumour necrosis factor related apoptosis inducing ligand

Indexed keywords

CASPASE 3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ARTICLE; CHRONIC HEPATITIS; DISEASE CLASSIFICATION; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM;

APOPTOSIS; CASPASE 3; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

HEPATITIS C VIRUS;

EID: 35348897860     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02863.x     Document Type: Article

References (28)

1. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996 12 1 9.
2. Bang S, Jeong EJ, Kim IK, Jung YK, Kim KS. Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction. J. Biol. Chem. 2000 275 36217 36222.
3. Yin XM, Ding WX. Death receptor activation-induced hepatocyte apoptosis and liver injury. Curr. Mol. Med. 2003 3 491 508.
4. Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995 3 673 682.
5. Kim IK, Jung YK, Noh YS et al. Functional screaning of gene supressing TRAIL-induced apoptosis: distinct inhibitory activities of Bcl-xL and Bcl-2. Br. J. Cancer 2003 88 910 917.
6. Strater J, Walczak H, Purkop T et al. TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology 2002 122 659 666.
7. Chou AH, Tsai HF, Wu Y et al. Hepatitis C virus core proteins modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 2005 174 2160 2166.
8. Prikhodko EA, Prikhodko GG, Siegel P et al. The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities. Virology 2004 329 53 67.
9. Siavoshian S, Abraham JD, Thumann C et al. Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. J. Med. Virol. 2005 75 402 411.
10. Lee SH, Kim YK, Kim CS et al. E2 of hepatitis C virus inhibits apoptosis. J. Immunol. 2005 175 8226 8235.
11. Saitou Y, Shiraki K, Fuke H et al. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Hum. Pathol. 2005 36 1066 1073.
12. Mundt B, Kuhnel F, Zender L et al. Involvement of TRAIL and its receptors in viral hepatitis. FASEB J. 2003 17 94 96.
13. Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology 1997 25 1527 1538.
14. Liendtke C, Groger N, Manns MP et al. Interferon-alfa enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J. Hepatol. 2006 44 342 349.
15. Nalepa G, Zukowska-Szczechowska E. Caspases and apoptosis: die and let live. Wiad. Lek. 2002 55 100 106.
16. Rotonda J, Nicholson DW, Fazil KM et al. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 1996 3 619 625.
17. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998 281 1312 1316.
18. Walker NP, Talanian RV, Brady KD et al. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2homodimer. Cell 1994 78 343 352.
19. Wilson KP, Black JA, Thomson JA et al. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 1994 370 270 275.
20. Chmielewski M. Liver apoptosis. Gastroenterol. Pol. 2003 10 453 459.
21. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 1991 13 372 374.
22. Piekarska A, Kubiak R, Omulecka A, Szymczak W, Piekarski J. Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C. Histopathology 2007 50 920 935.
23. Chen GY, He JQ, Lu GC et al. Association between TRAIL expression on peripheral blood lymphocytes and liver damage in chronic hepatitis B. World J. Gastroenterol. 2005 11 4090 4093.
24. Han LH, Sun WS, Ma CH et al. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J. Gastroenterol. 2002 8 1077 1080.
25. Poynard T, McHutchison J, Manns M et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002 122 1303 1313.
26. Bantel H, Lugering A, Poremba C et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 2001 34 758 767.
27. Farinati F, Cardin R, Fiorentino M et al. Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease. J. Viral Hepat. 2001 8 34 40.
28. Papakyriakou P, Tzardi M, Valatas V et al. Apoptosis and apoptosis related proteins in chronic viral liver disease. Apoptosis 2002 7 133 141.